Journal Information
Vol. 41. Issue 5.
Pages 295-296 (May 2005)
Share
Share
Download PDF
More article options
Vol. 41. Issue 5.
Pages 295-296 (May 2005)
Letters to the Editor
Full text access
Long-Term Treatment With Azithromycin in a Patient With Idiopathic Bronchiectasis
Visits
5361
L. Máiz Carro
Unidad de Fibrosis Quística, Servicio de Neumología, Hospital Ramón y Cajal, Madrid, Spain
This item has received
Article information
Full text is only aviable in PDF
REFERENCES
[1]
L Máiz, F Baranda, R Coll, C Prados, M Vendrell, A Escribano, et al.
Normativa del diagnóstico y tratamiento de la afección respiratoria en la fibrosis quística.
Arch Bronconeumol, 37 (2001), pp. 316-324
[2]
R Cantón, R Girón, L Martínez-Martínez, A Oliver, A Solé, S Valdezate, et al.
Patógenos multirresistentes en la fibrosis quística.
Arch Bronconeumol, 38 (2002), pp. 376-385
[3]
L Máiz Carro, R Cantón Moreno.
Tratamiento con azitromicina en la fibrosis quística.
Med Clin (Barc), 122 (2004), pp. 311-316
[4]
L Saiman, BC Marshall, N Mayer-Hamblett, JL Burns, AL Quittner, DA Cibene, et al.
Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.
JAMA, 290 (2003), pp. 1749-1756
[5]
K Kasahara, K Maeda, K Mikasa, K Uno, K Takahashi, M Konishi, et al.
Longterm azithromycin therapy for three patients with chronic lower respiratory tract infections.
J Infect Chemother, 10 (2004), pp. 42-44
[6]
T Nguyen, SG Louie, PM Beringer, MA Gill.
Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease.
Curr Opin Pulm Med, 8 (2002), pp. 521
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?